Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pavel

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Allergy|July 9, 2020
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skinAna B Pavel, Yael Renert-Yuval, Jianni Wu, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
The Journal of Allergy and Clinical Immunology|August 17, 2019
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trialRobert Bissonnette, Ana B Pavel, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with DupilumabBenjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Investigative Dermatology|May 7, 2019
Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy IndividualsEster Del Duca, Ana B Pavel, Celina Dubin, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot studyHee J Kim, Giselle K Singer, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|January 16, 2021
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adultsYael Renert-Yuval, Ester Del Duca, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseasesTali Czarnowicki, Helen He, Alexandra Leonard, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Allergy|July 9, 2020
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skinAna B Pavel, Yael Renert-Yuval, Jianni Wu, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
The Journal of Allergy and Clinical Immunology|August 17, 2019
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trialRobert Bissonnette, Ana B Pavel, Aisleen Diaz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with DupilumabBenjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Investigative Dermatology|May 7, 2019
Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy IndividualsEster Del Duca, Ana B Pavel, Celina Dubin, et al.
Archives of Dermatological Research|March 13, 2022
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VIHee J Kim, Ester Del Duca, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|January 13, 2021
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI: A randomized split-body pilot studyHee J Kim, Giselle K Singer, Ester Del Duca, et al.
The Journal of Allergy and Clinical Immunology|January 16, 2021
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adultsYael Renert-Yuval, Ester Del Duca, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseasesTali Czarnowicki, Helen He, Alexandra Leonard, et al.
The Journal of Investigative Dermatology|December 12, 2018
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic DermatitisEric L Simpson, Shinichi Imafuku, Yves Poulin, et al.
Pageof 8